Home/Xsensio/Esmeralda Megally
EM

Esmeralda Megally

CEO & Co-Founder

Xsensio

Xsensio Pipeline

DrugIndicationPhase
Lab-on-Skin Platform for Organ DysfunctionEarly detection of organ dysfunction (e.g., sepsis) in critical care, oncology, and post-surgical patientsPre-clinical/Development